Overview
INBS market data
Price History
INBS price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$20.04 Diluted earnings per share over the trailing twelve months.
- Beta
- 4.35 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -296.8% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.52 – $24.90 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $4.7M · P/B 4.20 · P/S 1.21.
Company News
8-K filing — INTELLIGENT BIO SOLUTIONS INC. (INBS)SEC EDGAR · Aug 11, 2026, 9:29 PM
Intelligent Bio Solutions Says It Completed 135-Participant Method Comparison Study, Concluding All Clinical Data Collection For FDA 510(k) Submission Targeted In H2 2026Benzinga · Aug 11, 2026, 12:32 PM
Intelligent Bio Solutions Completes Usability Study For Intelligent Fingerprinting Drug Screening System To Detect Opiate CodeineBenzinga · Aug 5, 2026, 12:37 PM
Intelligent Bio Solutions Announces Completion Of Interference Study Supporting FDA 510(k) Submission For Codeine Detection, Remains On Track To Submit In H2 2026Benzinga · Aug 3, 2026, 12:32 PM
Intelligent Bio Solutions Resolves All Cybersecurity, Software-Related Review Items For Its Upcoming FDA SubmissionBenzinga · Jul 23, 2026, 12:36 PM
Intelligent Bio Solutions Completes Precision Testing For Its Intelligent Fingerprinting Drug Screening System To Detect Opiate CodeineBenzinga · Jul 21, 2026, 12:32 PM
Intelligent Bio Solutions Starts Interference Study To Support FDA Submission For U.S. Market Clearance Of Its Intelligent Fingerprinting Drug Screening System For Codeine DetectionBenzinga · Jun 16, 2026, 12:40 PM
Intelligent Bio Solutions Initiates Multi-Site Method Comparison Study To Support FDA 510(k) Submission For US Market Clearance Of Intelligent Fingerprinting Drug Screening System For Opiate CodeineBenzinga · Jun 2, 2026, 12:36 PM